Sulfuric Acid

Sulfuric Acid

SCHEMBL340575

O=S(=O)([O-])[O-].OCCO.[K+].[K+]

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.53
TSHR P16473 2/20 0.42
ALDH1A1 P00352 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL9683363 0.92 TP53 (0.53) TP53TSHRALDH1A1MEN1KMT2A
Sulfuric Acid SCHEMBL28463257 0.92 TP53 (0.53) TP53TSHRALDH1A1MEN1KMT2A
Sulfuric Acid SCHEMBL28243636 0.92 TP53 (0.53) TP53TSHRALDH1A1MEN1KMT2A
Sulfuric Acid SCHEMBL27823538 0.92 TP53 (0.53) TP53TSHRALDH1A1MEN1KMT2A
Sulfuric Acid SCHEMBL4529057 0.92 TP53 (0.53) TP53TSHRALDH1A1MEN1KMT2A
Sulfuric Acid SCHEMBL11876709 0.92 TP53 (0.53) TP53TSHRALDH1A1MEN1KMT2A
Sulfuric Acid SCHEMBL3280245 0.92 TP53 (0.53) TP53TSHRALDH1A1MEN1KMT2A
Sulfuric Acid SCHEMBL28298208 0.92 TP53 (0.53) TP53TSHRALDH1A1MEN1KMT2A
Sulfuric Acid SCHEMBL2313306 0.92 TP53 (0.53) TP53TSHRALDH1A1MEN1KMT2A
Sulfuric Acid SCHEMBL10632478 0.92 TP53 (0.53) TP53TSHRALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025137404-A1 ODOR BINDING PROTEIN COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME K18, INC. (US) 2025-06-26 WO claimed
CN-109329553-A Soybean protein and preparation method, noodles and production method 想念食品股份有限公司 2019-02-15 CN claimed
CN-108548927-A Eliminate the latex immunoturbidimetry type pepsinogen II detection kit and preparation method thereof of serum lipid interference 武汉生之源生物科技股份有限公司 2018-09-18 CN claimed
US-20250332084-A1 PEPTIDE COMPOSITION AND RESPECTIVE USES UNIVERSIDADE DO MINHO (PT) 2025-10-30 US disclosed
US-20250319008-A1 HAIR COMPOSITIONS USES AND METHODS THEREOF FUNCTION INC (US) 2025-10-16 US disclosed
US-12383484-B2 Peptide composition and respective uses UNIVERSIDADE DO MINHO (PT) 2025-08-12 US disclosed
WO-2025137404-A1 ODOR BINDING PROTEIN COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME K18, INC. (US) 2025-06-26 WO disclosed
WO-2025137392-A1 CONDITIONER COMPOSITIONS, CLEANSER COMPOSITIONS AND METHODS OF USING THE SAME K18, INC. (US) 2025-06-26 WO disclosed
EP-4543547-A2 DETOX HAIR AND SCALP CLEANSER COMPOSITION, METHODS AND USES THEREOF K18, Inc. (US) 2025-04-30 EP disclosed
EP-4543406-A1 HAIR CLEANSER COMPOSITION, METHODS AND USES THEREOF K18, Inc. (US) 2025-04-30 EP disclosed
EP-4464307-A1 COSMETIC COMPOSITION AND METHODS OF MAKING THE SAME MPLUS COSMETICS S.R.L. (IT) 2024-11-20 EP disclosed
US-8097602-B1 Method of treating body insect infestation HOST PHARMACEUTICALS, LLC (US) 2012-01-17 US disclosed
EP-2337544-A2 USE OF MATRIX METALLOPROTEINASE INHIBITORS IN SKIN CARE Living Proof, Inc. (US) 2011-06-29 EP disclosed
WO-2009105617-A1 METHOD OF TREATING BODY INSECT INFESTATION HOST PHARMACEUTICALS, LLC (US) 2009-08-27 WO disclosed
US-20090068255-A1 USE OF MATRIX METALLOPROTEINASE INHIBITORS IN SKIN CARE LIVING PROOF, INC. 2009-03-12 US disclosed
WO-2008134712-A2 USE OF MATRIX METALLOPROTEINASE INHIBITORS IN SKIN CARE LIVING PROOF, INC. (US) 2008-11-06 WO disclosed
US-RE40534-E1 Clear conditioning detersive compositions containing polysiloxanes with at least one cyclic side chain CHEMSIL SILICONES, INC. (US) 2008-10-07 US disclosed
US-6642194-B2 Clear hair shampoo composition comprising detersive component, emulsifier component and polysiloxane component in amount effective as hair conditioner CHEMSIL SILICONES, INC. 2003-11-04 US disclosed
US-6605577-B1 Having a hindered amine group; hair shampoo CHEMSIL SILICONES, INC. 2003-08-12 US disclosed
US-20030134760-A1 Clear conditioning detersive compositions and methods for making the same CHEMSIL SILICONES, INC. 2003-07-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090068255-A1 USE OF MATRIX METALLOPROTEINASE INHIBITORS IN SKIN CARE MMP1, MMP9, MMP17 TP53 465/4885TSHR 2597/4885ALDH1A1 2338/4885
US-20030134760-A1 Clear conditioning detersive compositions and methods for making the same ASH2L, CD47, THOC2 TP53 4179/4885TSHR 3839/4885ALDH1A1 2065/4885
US-20250319008-A1 HAIR COMPOSITIONS USES AND METHODS THEREOF CUTA, KRT18, NACA TP53 3096/4885TSHR 3823/4885ALDH1A1 1848/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.